70
Participants
Start Date
September 12, 2017
Primary Completion Date
September 30, 2018
Study Completion Date
December 30, 2018
Topical tranexamic acid
Intraarticular application of tranexamic acid 3g in 60 ml normal saline into knee joint after closure of the joint capsule
Floseal®
Floseal® (Hemostatic matrix, 10ml, Baxter) was applied on potential bleeding sites: the femoral insertion of the posterior cruciate ligament, the lateral genicular artery after resection of the meniscus, the posterior capsule of the knee joint, the bony surfaces not covered by the implant as well as the pinholes (femur and tibia). The entire content of a 10 mL vial containing the active product (Floseal®) was used. The HM remained in place for 3 minutes and was then gently rinsed from the knee as recommended by the manufacturer (Baxter)
rivaroxaban (10mg)
Oral rivaroxaban (10mg) QD on PostOp Day 1 to 14.
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
Chang Gung Memorial Hospital
OTHER